Our Top Stories in Rheumatology: Daily tofacitinib, pregnancy outcomes, pediatric lupus, RA risk and more

May 24, 2019

In this slideshow, we highlight the news you may have missed:  Prescribing information for a newly approved treatment for pediatric lupus, new reports on negative pregnancy outcomes in PsA and ankylosing spondylitis, new information on the benefits of daily tofacitinib, and much more.

In this slideshow, we highlight the news you may have missed:  Prescribing information for a newly approved treatment for pediatric lupus, new reports on negative pregnancy outcomes in PsA and ankylosing spondylitis, new information on the benefits of daily tofacitinib, and much more.

x